Lexicon Pharmaceuticals, Inc. (LXRX) Deep Dive Video
Summary
Lexicon is a high-stakes, pipeline-driven cardiometabolic and non-opioid pain optionality play—financial runway secured to reach 2026–2027 catalysts, but outcomes are binary and pricing/regulatory pressures are rising.